PTGS2 and major depressive disorder: In addition, inhibition of COX2 has been shown in animal models to prevent anxiety development (Casolini et al. 2002), and celecoxib, a COX-2 inhibitor, has shown benefit as an augmentation agent to SSRIs in depression (Muller et al. 2006).